Clinical Trials
2 trialsNCT01521325 2016-09-30
A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers
Morphotek
Phase 1 Completed
NCT00325494 2014-07-17
A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer
Morphotek
Phase 1 Completed